New CINP Webinar! CINP’s Psychedelics Pharmacology GNC invites you to an upcoming webinar exploring the latest clinical trial evidence on psilocybin in the treatment of depression. Led by Dr. Joshua D. Rosenblat and Dr. Danica Johnson (University of Toronto & University Health Network, Canada), this session will provide a critical overview of efficacy, safety, and the methodological considerations shaping this rapidly evolving field. Participants will gain insight into the regulatory, ethical, and operational frameworks required to conduct compliant psilocybin trials, as well as key debates and unanswered questions guiding future research. Date: April 10, 2026 |
APPLICATION DEADLINE EXTENDED TO APRIL 13! CINP is pleased to introduce the Daniela Parolaro Prize, established in collaboration with the Zardi–Gori Foundation for Addiction Research. The prize recognizes researchers who are making impactful contributions to the field of addiction science and aims to support the next generation of leaders in neuropsychopharmacology. Nominations are now open - discover more about the prize, eligibility criteria, and how to apply. Extended Deadline for application: April 13, 2026. |
Follow CINP on Social Media Stay connected with the latest news, research highlights, events, and updates from CINP. Join our growing global community across social media: Facebook: X (Twitter): Instagram: LinkedIn: https://www.linkedin.com/company/international-college-of-neuropsychopharmacology/ YouTube: Follow us to stay informed, engage with the community, and be part of the conversation shaping the future of neuropsychopharmacology. |
We are excited to announce the recipients of the Rafaelsen Young Investigators Award 2026:
Due to a very high number of entries of exceptional quality, the following applicants have been awarded a President's Recognition for Young Investigators diploma:
Congratulations to all awardees! |
We are pleased to share a new Genomic Press Interview with Dr. Gabriella Gobbi, CINP President Elect, Professor of Psychiatry at McGill University, and Canada Research Chair in Therapeutics for Mental Health. From pioneering research on adolescent cannabis exposure and depression, to advancing novel melatonin receptor therapeutics, and early work on the neurobiology of psychedelics - Dr. Gobbi’s career exemplifies truly translational science. As the first woman elected CINP President in its 70-year history, she reflects on her journey from Italy to Canada, the clinical insights that shaped her research, and her vision for a neuropsychopharmacology that remains deeply connected to patient care. |
We are delighted to announce the recipients of the CINP Student Encouragement Award 2026:
The CINP Fellowship and Awards Committee decided to also award several President's Special Commendation Diplomas to appreciate the high quality of the received applications. Congratulations to all awardees! |
GLOBAL
| International Journal of Neuropsychopharmacology
Impact Factor: 3.7 |
-
January 30, 2026 10:48
-
December 17, 2025 15:46
-
November 27, 2025 18:17
